ClinVar Miner

Submissions for variant NM_002471.4(MYH6):c.4595G>T (p.Arg1532Leu)

dbSNP: rs34330111
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000154756 SCV000204436 uncertain significance not specified 2013-09-09 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Benign. The Arg1532Leu vari ant in MYH6 has not been reported in individuals with cardiomyopathy, but has be en identified in 0.2% (9/4406) of African American chromosomes by the NHLBI Exom e Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs34330111). Comp utational analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to t he protein. While the frequency of this variant suggests that it is more likely benign, it is too low to confidently rule out a disease-causing role. Additional information is needed to fully assess the clinical significance of this variant .
Labcorp Genetics (formerly Invitae), Labcorp RCV000228396 SCV000287429 likely benign Hypertrophic cardiomyopathy 14 2024-10-28 criteria provided, single submitter clinical testing
GeneDx RCV001719961 SCV000616985 likely benign not provided 2020-05-20 criteria provided, single submitter clinical testing
Ambry Genetics RCV000620512 SCV000736263 likely benign Cardiovascular phenotype 2018-04-09 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute RCV000623367 SCV000740622 uncertain significance Primary familial hypertrophic cardiomyopathy 2017-03-21 criteria provided, single submitter clinical testing
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego RCV000852692 SCV000995402 likely benign Cardiomyopathy 2018-04-23 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004544411 SCV004784641 likely benign MYH6-related disorder 2020-04-13 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Zaffran Lab, Genetics of Cardiac Diseases Laboratory, Marseille Medical Genetics RCV004765315 SCV005374736 uncertain significance Hypertrophic cardiomyopathy no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.